Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1989 3
1990 2
1992 1
1994 1
1996 3
1997 2
1998 2
1999 3
2001 2
2002 1
2003 5
2004 1
2005 3
2006 7
2007 1
2008 2
2009 3
2010 5
2011 2
2012 1
2013 3
2014 3
2015 2
2016 3
2019 1
2021 1
2022 1
2023 1
2024 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

61 results

Results by year

Filters applied: . Clear all
Page 1
Vedolizumab as induction and maintenance therapy for Crohn's disease.
Sandborn WJ, Feagan BG, Rutgeerts P, Hanauer S, Colombel JF, Sands BE, Lukas M, Fedorak RN, Lee S, Bressler B, Fox I, Rosario M, Sankoh S, Xu J, Stephens K, Milch C, Parikh A; GEMINI 2 Study Group. Sandborn WJ, et al. N Engl J Med. 2013 Aug 22;369(8):711-21. doi: 10.1056/NEJMoa1215739. N Engl J Med. 2013. PMID: 23964933 Free article. Clinical Trial.
Ozanimod as Induction and Maintenance Therapy for Ulcerative Colitis.
Sandborn WJ, Feagan BG, D'Haens G, Wolf DC, Jovanovic I, Hanauer SB, Ghosh S, Petersen A, Hua SY, Lee JH, Charles L, Chitkara D, Usiskin K, Colombel JF, Laine L, Danese S; True North Study Group. Sandborn WJ, et al. N Engl J Med. 2021 Sep 30;385(14):1280-1291. doi: 10.1056/NEJMoa2033617. N Engl J Med. 2021. PMID: 34587385 Clinical Trial.
Ozanimod Induction and Maintenance Treatment for Ulcerative Colitis.
Sandborn WJ, Feagan BG, Wolf DC, D'Haens G, Vermeire S, Hanauer SB, Ghosh S, Smith H, Cravets M, Frohna PA, Aranda R, Gujrathi S, Olson A; TOUCHSTONE Study Group. Sandborn WJ, et al. N Engl J Med. 2016 May 5;374(18):1754-62. doi: 10.1056/NEJMoa1513248. N Engl J Med. 2016. PMID: 27144850 Free article. Clinical Trial.
The "return" of hepatitis B.
Krastev ZA. Krastev ZA. World J Gastroenterol. 2006 Nov 28;12(44):7081-6. doi: 10.3748/wjg.v12.i44.7081. World J Gastroenterol. 2006. PMID: 17131468 Free PMC article. Review.
Tenofovir disoproxil fumarate versus adefovir dipivoxil for chronic hepatitis B.
Marcellin P, Heathcote EJ, Buti M, Gane E, de Man RA, Krastev Z, Germanidis G, Lee SS, Flisiak R, Kaita K, Manns M, Kotzev I, Tchernev K, Buggisch P, Weilert F, Kurdas OO, Shiffman ML, Trinh H, Washington MK, Sorbel J, Anderson J, Snow-Lampart A, Mondou E, Quinn J, Rousseau F. Marcellin P, et al. Among authors: krastev z. N Engl J Med. 2008 Dec 4;359(23):2442-55. doi: 10.1056/NEJMoa0802878. N Engl J Med. 2008. PMID: 19052126 Free article. Clinical Trial.
The pharmacokinetics of paroxetine in patients with liver cirrhosis.
Krastev Z, Terziivanov D, Vlahov V, Maleev A, Greb WH, Eckl KM, Dierdorf HD, Wolf D. Krastev Z, et al. Acta Psychiatr Scand Suppl. 1989;350:91-2. doi: 10.1111/j.1600-0447.1989.tb07182.x. Acta Psychiatr Scand Suppl. 1989. PMID: 2530799 No abstract available.
Chronic Epstein-Barr virus-related hepatitis in immunocompetent patients.
Petrova M, Muhtarova M, Nikolova M, Magaev S, Taskov H, Nikolovska D, Krastev Z. Petrova M, et al. Among authors: krastev z. World J Gastroenterol. 2006 Sep 21;12(35):5711-6. doi: 10.3748/wjg.v12.i35.5711. World J Gastroenterol. 2006. PMID: 17007027 Free PMC article.
Isoprinosine affects serum cytokine levels in healthy adults.
Petrova M, Jelev D, Ivanova A, Krastev Z. Petrova M, et al. Among authors: krastev z. J Interferon Cytokine Res. 2010 Apr;30(4):223-8. doi: 10.1089/jir.2009.0057. J Interferon Cytokine Res. 2010. PMID: 20038210 Clinical Trial.
61 results